UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050076
Receipt number R000056958
Scientific Title Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis
Date of disclosure of the study information 2023/01/25
Last modified on 2024/02/05 15:57:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis

Acronym

Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis

Scientific Title

Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis

Scientific Title:Acronym

Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis

Region

Japan


Condition

Condition

Atopic dermatitis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will examine the feasibility of using ePRO for disease management of atopic dermatitis patients to activate communication between patients and doctors, increase patient satisfaction with treatment, and improve treatment effects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Patients' satisfaction and challenges with using ePRO will be assessed using patient questionnaires at the beginning and after 8 weeks.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The ePRO system uses Integrity Healthcare's YaDoc. After obtaining consent for participation in this study from the research subject patient, install the application on the smartphone owned by the research subject according to the YaDoc operation manual. The research subjects are at home during the treatment days, and periodically, once a week, use YaDoc to answer medical questions and record symptoms. POEM and ADCT, which are self-assessment tools for atopic dermatitis, are used for interviews and symptom records. For pruritus, respond using the pruritus NRS (Numerical Rating Scale) to answer the mean of pruritus for a week on an 11-point scale from 0 (no pruritus) to 10 (unbearable pruritus). Optionally, and if possible, record exacerbations using YaDoc's photography function. The recording period shall be 8 weeks. Before the start and at the end of the study, a questionnaire survey will be conducted on the research subjects to examine the usefulness of medical care using ePRO.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1 Patients with atopic dermatitis who are 18 years of age or older at the time of informed consent
2 Patients judged by the investigator that patient data collection by ePRO is effective
3 Smartphone (iOS, Android) users

Key exclusion criteria

1 Cases where it is difficult to see, operate, and understand YaDoc and smartphones
2 Patients participating in a clinical study with other interventions at the start of this study
3 Other patients who are judged by doctors to be unfavorable subjects

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Motoi
Middle name
Last name Takenaka

Organization

Nagasaki University Hospital

Division name

Dermatology and Allergology

Zip code

8528501

Address

1-7-1 sakamoto, Nagasaki-city

TEL

0958197200

Email

m-take@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Motoi
Middle name
Last name Takenaka

Organization

Nagasaki University Hospital

Division name

Dermatology and Allergology

Zip code

8528501

Address

1-7-1 sakamoto, Nagasaki-city

TEL

0958197200

Homepage URL


Email

m-take@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital Clinical Research Ethics Committee

Address

1-7-1 sakamoto, Nagasaki-city

Tel

0958192503

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 01 Month 24 Day

Date of IRB

2023 Year 01 Month 24 Day

Anticipated trial start date

2023 Year 03 Month 01 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry

2023 Year 08 Month 31 Day

Date trial data considered complete

2023 Year 08 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 18 Day

Last modified on

2024 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056958


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name